Activist Commentary: Elliott is a very successful and astute activist investor. The firm's team includes analysts from ...

Q1 2025 Earnings Call Transcript May 9, 2025 Operator: Greetings and welcome to the Collegium Pharmaceutical First Quarter ...

Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS); full healthy volunteer data expected in 2H25 On-track to enable dosing ...

Virtual chronic care provider Omada Health has filed to go public in the United States, the latest in a string of healthcare ...

Vesicor Therapeutics, a San Gabriel-based biotech firm developing p53-based cancer treatments, is set to go public through a ...

Kodak is investing $20 million in a new pharmaceutical manufacturing facility at Eastman Business Park, expanding its ...

Angela Hwang spent nearly three decades at Pfizer before joining Flagship Pioneering in 2025 as a CEO-partner and the CEO of ...

President Trump announced a trade agreement with the U.K. on Thursday, the first country-specific deal since the April 2 ...

In April 2025, Terns enrolled the first patient in the dose expansion portion of the Phase 1 CARDINAL study of TERN-701 for CML. Patients will be randomized to one of two dose cohorts (320 mg or 500 ...

Wellness company Pharmavite, owners of the Nature Made brand, officially opened its 225,000-square-foot, $250 million plant ...

CEO Richard Daly highlighted Catalyst's strong start to 2025 with $141.4 million in total net revenues, reflecting a 43.6% year-over-year growth. Key contributors included FIRDAPSE, AGAMREE, and ...

The company added to a recent flurry of pledges by pharmaceutical companies, promising $11 billion in new capital and ...